Quick Answer
Onconetix, Inc. reported Total Assets of $24.93 million for the year ending 2025.
- Onconetix, Inc. showed a decrease of -11.5% in Total Assets from 2024 to 2025.
- This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $19.34 million | Q2 2022: $23.63 million | Q3 2022: $30.16 million | Q1 2023: $22.50 million | Q2 2023: $29.75 million | Q3 2023: $27.88 million | Q1 2024: $75.03 million | Q2 2024: $59.46 million | Q3 2024: $61.92 million | Q1 2025: $18.78 million | Q2 2025: $19.12 million | Q3 2025: $19.68 million.
- Over the full 5 years of available data (2021 to 2025), Onconetix, Inc.'s Total Assets has grown by 708.1%.
- Historical annual values: Fiscal year 2025: $24.93 million | Fiscal year 2024: $28.18 million | Fiscal year 2023: $87.52 million | Fiscal year 2022: $26.31 million | Fiscal year 2021: $3.08 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: